secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001640334-23-001126
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq letter dated June 22, 2023 cites LEXX not meeting $1.00 bid price requirement.
- Company has until December 19, 2023 to close at or above $1.00 for 10 consecutive days.
- If not compliant, may qualify for additional 180-day period; could consider reverse stock split.
- No immediate effect on listing; common stock continues trading on Nasdaq under LEXX.
- Company intends to monitor bid price and evaluate options but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001126/0001640334-23-001126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001126/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-001126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer